Home › Funds › Royce & Associates › SPRY
Royce & Associates position in SPRY
ARS PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)54.02K sh
Reported value held$432.73K
Portfolio Weight0.00%
First reportedQ1 2023
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2023 | 303.90K | $1.98K | New |
| Q2 2023 | 463.70K | $3.11M | Add |
| Q3 2023 | 463.70K | $1.75M | Hold |
| Q4 2023 | 473.70K | $2.60M | Add |
| Q1 2024 | 558.70K | $5.71M | Add |
| Q2 2024 | 645.70K | $5.49M | Add |
| Q3 2024 | 691.46K | $10.03M | Add |
| Q4 2024 | 929.61K | $9.81M | Add |
| Q1 2025 | 642.77K | $8.09M | Reduce |
| Q2 2025 | 256.27K | $4.47M | Reduce |
| Q4 2025 | 207.05K | $2.41M | New |
| Q1 2026 | 54.02K | $433.81K | Reduce |
| Q2 2026 | 54.02K | $432.73K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding SPRY
- BlackRock Inc 5.31M sh · $42.54M · Q2 2026
- Vanguard Group 3.51M sh · $40.88M · Q4 2025
- Capital World Investors 2.75M sh · $22.07M · Q2 2026
- Millennium Management 2.52M sh · $20.19M · Q2 2026
- UBS Group AG 1.94M sh · $15.54M · Q2 2026
- Geode Capital Management 1.70M sh · $13.61M · Q2 2026
- Third Point 1.00M sh · $8.01M · Q2 2026
- Citadel Advisors 566.56K sh · $4.54M · Q2 2026
- Charles Schwab Investment Management 551.42K sh · $4.42M · Q2 2026
- Northern Trust Corp 549.06K sh · $4.40M · Q2 2026
- Bank of America Corp 463.26K sh · $3.71M · Q2 2026
- Fidelity International (FIL) 455.57K sh · $3.65M · Q2 2026